Recent discoveries pointed out that these neoplasms, with a clinical course that differs from their pediatric and adult counterparts, carry specific molecular alterations, namely kinase (ALK, NTRK1/2/3, ROS1, or MET) gene fusions [17]. The gene discussed is ALK; the disease is neoplasm.